Leukocytes (FSC-SSC): 58.8% of the total number of cells Viable Leukocytes (FSC-FL8): 92.1% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 0.2% of Viable Leukocytes Leukocytes (FSC-SSC): 57.1% of the total number of cells Viable Leukocytes (FSC-FL8): 94.5% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 0.8% of Viable Leukocytes Leukocytes (FSC-SSC): 55.6% of the total number of cells Viable Leukocytes (FSC-FL8): 93.1% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 43.1% of Viable Leukocytes Doner-derived B cells (FL2-FL6): 30.9% of Donor-derived Viable Leukocytes Doner-derived T cells (FL3-FL6): 30.4% of Donor-derived Viable Leukocytes Doner-derived Myeloid cells (FL2-FL6): 38.8% of Donor-derived Viable Leukocytes Leukocytes (FSC-SSC): 54.8% of the total number of cells Viable Leukocytes (FSC-FL8): 97.2% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 0.1% of Viable Leukocytes Leukocytes (FSC-SSC): 53.6% of the total number of cells Viable Leukocytes (FSC-FL8): 92.5% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 10.8% of Viable Leukocytes Doner-derived B cells (FL2-FL6): 29.0% of Donor-derived Viable Leukocytes Doner-derived T cells (FL3-FL6): 31.5% of Donor-derived Viable Leukocytes Doner-derived Myeloid cells (FL2-FL6): 39.5% of Donor-derived Viable Leukocytes Leukocytes (FSC-SSC): 56.6% of the total number of cells Viable Leukocytes (FSC-FL8): 92.5% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 45.8% of Viable Leukocytes Doner-derived B cells (FL2-FL6): 29.5% of Donor-derived Viable Leukocytes Doner-derived T cells (FL3-FL6): 31.0% of Donor-derived Viable Leukocytes Doner-derived Myeloid cells (FL2-FL6): 39.5% of Donor-derived Viable Leukocytes Leukocytes (FSC-SSC): 48.8% of the total number of cells Viable Leukocytes (FSC-FL8): 95.4% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 3.8% of Viable Leukocytes Doner-derived B cells (FL2-FL6): 33.6% of Donor-derived Viable Leukocytes Doner-derived T cells (FL3-FL6): 35.0% of Donor-derived Viable Leukocytes Doner-derived Myeloid cells (FL2-FL6): 31.4% of Donor-derived Viable Leukocytes Leukocytes (FSC-SSC): 55.8% of the total number of cells Viable Leukocytes (FSC-FL8): 97.0% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 0.8% of Viable Leukocytes Leukocytes (FSC-SSC): 48.7% of the total number of cells Viable Leukocytes (FSC-FL8): 92.4% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 35.8% of Viable Leukocytes Doner-derived B cells (FL2-FL6): 29.6% of Donor-derived Viable Leukocytes Doner-derived T cells (FL3-FL6): 28.0% of Donor-derived Viable Leukocytes Doner-derived Myeloid cells (FL2-FL6): 42.4% of Donor-derived Viable Leukocytes Leukocytes (FSC-SSC): 55.8% of the total number of cells Viable Leukocytes (FSC-FL8): 93.5% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 55.4% of Viable Leukocytes Doner-derived B cells (FL2-FL6): 31.1% of Donor-derived Viable Leukocytes Doner-derived T cells (FL3-FL6): 32.1% of Donor-derived Viable Leukocytes Doner-derived Myeloid cells (FL2-FL6): 66.8% of Donor-derived Viable Leukocytes Leukocytes (FSC-SSC): 56.8% of the total number of cells Viable Leukocytes (FSC-FL8): 93.7% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 52.6% of Viable Leukocytes Doner-derived B cells (FL2-FL6): 32.5% of Donor-derived Viable Leukocytes Doner-derived T cells (FL3-FL6): 32.0% of Donor-derived Viable Leukocytes Doner-derived Myeloid cells (FL2-FL6): 66.5% of Donor-derived Viable Leukocytes Leukocytes (FSC-SSC): 52.9% of the total number of cells Viable Leukocytes (FSC-FL8): 91.7% of Leukocytes Donor-derived Viable Leukocytes (FL1-FL4): 49.8% of Viable Leukocytes Doner-derived B cells (FL2-FL6): 30.1% of Donor-derived Viable Leukocytes Doner-derived T cells (FL3-FL6): 31.3% of Donor-derived Viable Leukocytes Doner-derived Myeloid cells (FL2-FL6): 68.6% of Donor-derived Viable Leukocytes